Insights into the novel EEF1D::ALK fusion transcript in FISH ‐negative ALK ‐positive anaplastic large cell lymphoma
British Journal of Haematology · 2026-05 · 208 (5) · 1821-1825
DOI: 10.1111/bjh.70410 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 03.03.2026. Verfasst von Sachleen K Tuteja und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
particularly unique and diagnostically challenging because FISH, which is the standard method for detecting ALK rearrangements and is usually reliable, failed to detect the ALK fusion. We hypothesize that the FISH assay was negative because the EEF1D::ALK fusion resulted from a small insertion/rear-rangement on chromosome 2, which caused minimal physical separation between the 5 ′ and 3 ′ ALK probes. Because this separation falls below the resolution threshold of break-apart FISH, the rearrangement would not be detected despite the presence of a true oncogenic fusion. In conclusion, this study reports a novel EEF1D::ALK fusion transcript in a case of ALK-positive ALCL, emphasizing the value of RNA-based NGS in detecting rare and/or atypical ALK fusion transcripts. Identifying ALK fusions may be crucial for guiding treatment decisions across the spectrum of ALK-driven neoplasms. ALK inhibitors represent a highly effective, targeted therapy for patients with relapsed/refractory ALK-positive ALCL and other ALK-driven cancers, demonstrating high response rates and excellent durability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Weinberg College of Arts and Sciences, Northwestern University, Evanston, Illinois, USA.
- Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Sachleen K Tuteja, Aida I Richardson
Zitieren
APA
Tuteja, S. K., Wlodaver, A., Kirschmann, D., Caparelli, E., Yap, K. L., Schubert, J., Zhong, Y., Li, M. M., Leuer, K., Gong, S., & Richardson, A. I. (2026). Insights into the novel EEF1D::ALK fusion transcript in FISH ‐negative ALK ‐positive anaplastic large cell lymphoma. British Journal of Haematology, 208(5), 1821-1825. https://doi.org/10.1111/bjh.70410
Vancouver
Tuteja SK, Wlodaver A, Kirschmann D, Caparelli E, Yap KL, Schubert J, et al. Insights into the novel EEF1D::ALK fusion transcript in FISH ‐negative ALK ‐positive anaplastic large cell lymphoma. British Journal of Haematology. 2026;208(5):1821-1825. doi:10.1111/bjh.70410
BibTeX
@article{Tuteja2026,
author = {Tuteja, Sachleen K and Wlodaver, Alissa and Kirschmann, Dawn and Caparelli, Edward and Yap, Kai Lee and Schubert, Jeffrey and Zhong, Yiming and Li, Marilyn M and Leuer, Katrin and Gong, Shunyou and Richardson, Aida I},
title = {Insights into the novel EEF1D::ALK fusion transcript in FISH ‐negative ALK ‐positive anaplastic large cell lymphoma},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {5},
pages = {1821--1825},
doi = {10.1111/bjh.70410}
}
EUVIMED